Progressive Multiple Sclerosis Clinical Trials

46 clinical trials for Progressive Multiple Sclerosis across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS) — RECRUITING · PHASE2
• Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS) — RECRUITING · PHASE1
• Obe-cel in Refractory Progressive Forms of Multiple Sclerosis — RECRUITING · PHASE1
• Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients — RECRUITING · NA
• Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis — RECRUITING · PHASE1
• Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis — RECRUITING
• Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis — RECRUITING · NA
• Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis — RECRUITING · PHASE2
• A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis — ACTIVE_NOT_RECRUITING · PHASE1
• Prospective, randomized, double-blind, placebo-controlled, single-center comparative trial evaluating oral Istradefylline 40 mg once daily for reducing microglial activation in the brain of patients with progressive multiple sclerosis (MS) — TERMINATED · PHASE2
• A Study of Oxidative Pathways in MS Fatigue — COMPLETED · PHASE2
• A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis — ACTIVE_NOT_RECRUITING · PHASE3
• RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis — WITHDRAWN · PHASE1
• A single-center, randomized, double blind, placebo-controlled, parallel-group, proof-of-concept trial to assess the efficacy and safety of ACT-1004-1239 in adults with progressive multiple sclerosis — TERMINATED · PHASE2
• A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases — NOT_YET_RECRUITING · PHASE1
• Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis — SUSPENDED · PHASE3
• Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS) — COMPLETED · NA
• The Effects of a 12-week In-phase Bilateral Exercise Programme on the Corticospinal Plasticity in People With Progressive Multiple Sclerosis — COMPLETED · NA
• A phase 2, randomized, patient and assessor blind, multicentre study comparing foetal neural stem cells transplantation to sham procedure in progressive multiple sclerosis (STEMS2) — TERMINATED · PHASE2
• Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis — ACTIVE_NOT_RECRUITING · PHASE1
• An Open-Label, Single-Arm 4-Year Study to Evaluate Effectiveness and Safety of Ocrelizumab Treatment in Patients with Progressive Multiple Sclerosis — TERMINATED · PHASE3
• LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB IN FRENCH PATIENTS WITH PROGRESSIVE MS: CONSONANCE EXTENSION STUDY — TERMINATED · PHASE3
• Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis — COMPLETED · NA
• ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis — ACTIVE_NOT_RECRUITING · PHASE2
• ABA-101 in Participants With Progressive Multiple Sclerosis — ACTIVE_NOT_RECRUITING · PHASE1
• Effect of Variance on Error Correction During Coupling — COMPLETED · NA
• Telerehabilitation in Progressive Multiple Sclerosis — OTHER · NA
• Multiple Sclerosis Prediction and Monitoring of Progression Study — OTHER · NA
• Osmotin Plant Protein for Progressive Multiple Sclerosis — OTHER · NA
• A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis — COMPLETED · PHASE1
• A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668 — COMPLETED
• A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis — COMPLETED · PHASE1
• G-EO Gait Rehabilitation Training in Progressive Multiple Sclerosis — COMPLETED · NA
• Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis — COMPLETED
• Neural Stem Cell Transplantation in Multiple Sclerosis Patients — COMPLETED · PHASE1
• Efficacy of Early Harvest Olive Oil in Cognition of Primary (PPMS) or Secondary (SPMS) Progressive Multiple Sclerosis — COMPLETED · NA
• Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple Sclerosis — TERMINATED · NA
• A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis — COMPLETED · PHASE1
• Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis — COMPLETED · PHASE1
• Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS) — OTHER · PHASE2
• Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis — OTHER
• Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis — COMPLETED · PHASE2
• Access, Use and Opinions of Physiotherapy and Rehabilitation Services of People With Progressive MS in the UK. — COMPLETED
• A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis — COMPLETED · PHASE1
• Cyclic Oral Methylprednisolone Trial in Multiple Sclerosis — COMPLETED · PHASE2
• Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica — OTHER · PHASE1

Refine this search